Calidi Biotherapeutics (Calidi Biotherapeutics) FCF Yield % : -231.74 (As of May. 16, 2024)

View and export this data going back to 2023. Start your Free Trial

What is Calidi Biotherapeutics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Calidi Biotherapeutics's Trailing 12-Month Free Cash Flow is $-27.57 Mil, and Market Cap is $12.32 Mil. Therefore, Calidi Biotherapeutics's FCF Yield % for today is -231.74%.

The historical rank and industry rank for Calidi Biotherapeutics's FCF Yield % or its related term are showing as below:

CLDI' s FCF Yield % Range Over the Past 10 Years
Min: -231.74 Med: -6.44 Max: -1.91
Current: -231.74

During the past 4 years, the highest FCF Yield % of Calidi Biotherapeutics was -1.91%. The lowest was -231.74%. And the median was -6.44%.

CLDI's FCF Yield % is ranked worse than
93.25% of 1556 companies
in the Biotechnology industry
Industry Median: -14.305 vs CLDI: -231.74

Calidi Biotherapeutics's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

Calidi Biotherapeutics FCF Yield % Historical Data

The historical data trend for Calidi Biotherapeutics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Calidi Biotherapeutics FCF Yield % Chart

Calidi Biotherapeutics Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

FCF Yield %

-51.40

Calidi Biotherapeutics Quarterly Data
	Dec20	Sep21	Dec21	Sep22	Dec22	Jun23	Sep23	Dec23
FCF Yield %	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Calidi Biotherapeutics's FCF Yield %

For the Biotechnology subindustry, Calidi Biotherapeutics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Calidi Biotherapeutics's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Calidi Biotherapeutics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Calidi Biotherapeutics's FCF Yield % falls into.

Calidi Biotherapeutics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Calidi Biotherapeutics's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-27.568	/	53.638522
	=	-51.40%

Calidi Biotherapeutics's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	0	*	4	/	53.638522
	=	0.00%

Calidi Biotherapeutics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Calidi Biotherapeutics FCF Yield % Related Terms

Thank you for viewing the detailed overview of Calidi Biotherapeutics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Calidi Biotherapeutics (Calidi Biotherapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Calidi Biotherapeutics Inc (AMEX:CLDI) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

11011 North Torrey Pines Road, Suite 200, La Jolla, CA, USA, 92037

Website

https://www.calidibio.com

Calidi Biotherapeutics Inc is a clinical stage immuno-oncology company pioneering the development and commercialization of novel, potent and efficient stem cell-based platforms for delivery and potentiation of oncolytic viruses for the treatment of cancer.